CING
CING
NASDAQ · Pharmaceuticals

Cingulate Inc

$5.35
+0.11 (+2.10%)
As of Sep 21, 5:00 PM ET ·
Analyst Consensus
Strong Buy
10
Analysts
Moderate
Coverage
Buy 9 90%
Hold 1 10%
Sell 0 0%
Price Target
Analyst Price Target +168.8% upside
Low Target $9.95
Average Target $14.38
High Target $17.66
Current Price $5.35
Current
$5.35
Target
$14.38
$9.95 $14.38 avg $17.66
Scenario Analysis
Bear Case
$9.95
86.0%
Low target
Base Case
$14.38
+168.8%
Avg target
Bull Case
$17.66
+230.1%
High target
Risk/Reward
2.7x
Favorable
Price in Context
52-Week High
$11.89
-55.0% from high
52-Week Low
$3.16
+69.3% from low
Target vs 52W High
$14.38
+20.9% vs high
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
Strong Buy 38 79% $1,330.33 +13.7%
RDY
Dr. Reddy's Laboratories
Strong Sell 45 31% +0.0%
JNJ
Johnson & Johnson
Buy 31 71% $299.55 +11.3%
MRK
Merck & Co. Inc.
Buy 36 72% $159.27 +5.5%
PFE
Pfizer Inc.
Hold 36 39% $33.90 +21.4%
BMY
Bristol-Myers Squibb Co
Hold 35 43% $174.50 +180.3%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 16 88% $36.26 -38.0%
ZTS
Zoetis Inc
Hold 24 50% $209.87 +188.0%